Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Pulmonary Hypertension, August 2023 Free Subscription Abstracts Retrieve all available abstracts of the following 147 articles: HTML format

Single Articles

1. WANG X, Liu M, Li J, Wang Z, et al
   Relationship between quality of life, fear of disease progression, and coping styles in patients with pulmonary hypertension: A network analysis.
   Res Nurs Health. 2023 Aug 3. doi: 10.1002/nur.22333.
   PubMed    
   Abstract available
   
   

2. MENG XP, Sun XB, Xu WQ, Tao XC, et al
   [Comparison of pulmonary vascular tortuosity and fractal dimension in patients with chronic thromboembolic pulmonary disease and chronic thromboembolic pulmonary hypertension].
   Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:774-780.
   PubMed    
   Abstract available
   
   

3. ENNIS S, Sandhu HK, Bruce J, Seers K, et al
   Development of a complex exercise rehabilitation intervention for people with pulmonary hypertension: the supervised pulmonary hypertension exercise rehabilitation (SPHERe) trial.
   BMJ Open. 2023;13:e066053.
   PubMed    
   Abstract available
   
   

4. SONG R, Wang P, Yang L, Liu J, et al
   Association of FOXO3A with right ventricular myocardial fibrosis and its detection by speckle-tracking echocardiography in pulmonary hypertension.
   Echocardiography. 2023 Aug 3. doi: 10.1111/echo.15663.
   PubMed    
   Abstract available
   
   

5. AKIYAMA T, Sadahiro T, Yamada Y, Fujita R, et al
   Flk1 Deficiency and Hypoxia Synergistically Promote Endothelial Dysfunction, Vascular Remodeling, and Pulmonary Hypertension.
   Arterioscler Thromb Vasc Biol. 2023 Aug 3. doi: 10.1161/ATVBAHA.123.319266.
   PubMed    
   Abstract available
   
   

6. KIM J, Jeong J, Park K, Shin K, et al
   Evaluation of improved transvenous heartworm extraction brush in dogs with caval syndrome.
   J Vet Sci. 2023;24:e46.
   PubMed    
   Abstract available
   
   

7. TITZ A, Mayer L, Appenzeller P, Muller J, et al
   Long-term outcome of patients with combined post- and pre-capillary pulmonary hypertension.
   Eur Heart J Open. 2023;3:oead069.
   PubMed    
   Abstract available
   
   

8. SHI H, Zhao Y, Li S, Wu H, et al
   TNF-alpha and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats.
   Open Life Sci. 2023;18:20220650.
   PubMed    
   Abstract available
   
   

9. BAUERSACHS J, Rosenkranz S
   Pulmonary hypertension.
   Herz. 2023;48:257-258.
   PubMed    
   
   
   

10. KHATTAR G, Mustafa A, Siddiqui FS, Gharib KE, et al
    Pulmonary hypertension: An unexplored risk factor for stroke in patients with atrial fibrillation.
    J Stroke Cerebrovasc Dis. 2023;32:107247.
    PubMed    
    Abstract available
    
    

11. SUN ML, Zhu YJ, Zhou YP, Zhu XJ, et al
    Percutaneous transluminal pulmonary angioplasty for Takayasu arteritis-associated pulmonary hypertension: A single-arm meta-analysis.
    Catheter Cardiovasc Interv. 2023 Jul 31. doi: 10.1002/ccd.30773.
    PubMed    
    Abstract available
    
    

12. BAGHERI M, Agrawal V, Annis J, Shi M, et al
    Genetics of Pulmonary Pressure and Right Ventricle Stress Identify Diabetes as a Causal Risk Factor.
    J Am Heart Assoc. 2023;12:e029190.
    PubMed    
    Abstract available
    
    

13. KAZMIRCZAK F, Prins KW
    Diabetes Enters Stage Right: Genetic Association Studies Suggest Diabetes Promotes Pulmonary Hypertension and Right Ventricular Dysfunction.
    J Am Heart Assoc. 2023;12:e030954.
    PubMed    
    
    
    

14. KANEZAWA M, Naito T, Shimokawahara H, Ogawa A, et al
    Rescue balloon pulmonary angioplasty for refractory heart failure in chronic thromboembolic pulmonary hypertension complicated with takotsubo cardiomyopathy.
    J Cardiol Cases. 2023;28:79-82.
    PubMed    
    Abstract available
    
    

15. MINKIN R, Hopson R, Ramasubbu K, Gharanei M, et al
    Pulmonary hypertension predicts higher mortality in patients admitted with severe COVID-19 infection.
    SAGE Open Med. 2023;11:20503121231187755.
    PubMed    
    Abstract available
    
    

16. SULLIVAN RT, Raj JU, Austin ED
    Recent Advances in Pediatric Pulmonary Hypertension: Implications for Diagnosis and Treatment.
    Clin Ther. 2023 Jul 28:S0149-2918(23)00251.
    PubMed    
    Abstract available
    
    

17. BERNARDO RJ, de Jesus Perez VA
    Health Care Disparities in Pulmonary Arterial Hypertension.
    Clin Chest Med. 2023;44:543-554.
    PubMed    
    Abstract available
    
    

18. MUMBY S, Perros F, Grynblat J, Manaud G, et al
    Differential responses of pulmonary vascular cells from PAH patients and controls to TNFalpha and the effect of the BET inhibitor JQ1.
    Respir Res. 2023;24:193.
    PubMed    
    Abstract available
    
    

19. PARK DY, Heo W, Kang M, Ahn T, et al
    Role of TRPC3 in Right Ventricular Dilatation under Chronic Intermittent Hypoxia in 129/SvEv Mice.
    Int J Mol Sci. 2023;24:11284.
    PubMed    
    Abstract available
    
    

20. CINAR C, Yildizeli SO, Balcan B, Yildizeli B, et al
    Determinants of Severe Nocturnal Hypoxemia in Adults with Chronic Thromboembolic Pulmonary Hypertension and Sleep-Related Breathing Disorders.
    J Clin Med. 2023;12:4639.
    PubMed    
    Abstract available
    
    

21. STARK P, Chang EY
    Sleep Apnea Combined with Pulmonary Hypertension in a Veteran Patient Population.
    J Clin Med. 2023;12:4634.
    PubMed    
    Abstract available
    
    

22. KACPRZAK A, Tomkowski W, Szturmowicz M
    Pulmonary Hypertension in the Course of Interstitial Lung Diseases-A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy.
    Diagnostics (Basel). 2023;13:2354.
    PubMed    
    Abstract available
    
    

23. ZHENG X, Diktonaite K, Qiu H
    Epigenetic Reader Bromodomain-Containing Protein 4 in Aging-Related Vascular Pathologies and Diseases: Molecular Basis, Functional Relevance, and Clinical Potential.
    Biomolecules. 2023;13:1135.
    PubMed    
    Abstract available
    
    

24. MACE EH, Kimlinger MJ, Billings FT 4th, Lopez MG, et al
    Targeting Soluble Guanylyl Cyclase during Ischemia and Reperfusion.
    Cells. 2023;12:1903.
    PubMed    
    Abstract available
    
    

25. COLPMAN P, Dasgupta A, Archer SL
    The Role of Mitochondrial Dynamics and Mitotic Fission in Regulating the Cell Cycle in Cancer and Pulmonary Arterial Hypertension: Implications for Dynamin-Related Protein 1 and Mitofusin2 in Hyperproliferative Diseases.
    Cells. 2023;12:1897.
    PubMed    
    Abstract available
    
    

26. KARIKI O, Karyofyllis P, Mililis P, Saplaouras A, et al
    Electrocardiographic changes after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: Data from the Hellenic Registry.
    J Electrocardiol. 2023;81:26-31.
    PubMed    
    Abstract available
    
    

27. LEVIN JC, Sheils CA, Hayden LP
    Pre-Flight Hypoxemia Challenge Testing in Bronchopulmonary Dysplasia.
    Pediatrics. 2023;152:e2022061001.
    PubMed    
    Abstract available
    
    

28. PARATI G, Piepoli M
    Issue 30.10 focus on arterial hypertension.
    Eur J Prev Cardiol. 2023;30:913-915.
    PubMed    
    
    
    

29. ALEXANDRE A, Furtado I, Carvalho L, Goncalves F, et al
    Transitioning intravenous epoprostenol to oral selexipag in idiopathic pulmonary arterial hypertension: a case report.
    ESC Heart Fail. 2023;10:2722-2727.
    PubMed    
    Abstract available
    
    

30. LI N, Wu Q, Meng J, Feng C, et al
    Macitentan treatment of portopulmonary hypertension with hepatopulmonary syndrome: a case report and literature review.
    ESC Heart Fail. 2023;10:2718-2721.
    PubMed    
    Abstract available
    
    

31. YAYLALI YT, Yagmur B, Sinan UY, Meric M, et al
    Risk Assessment Tool Implementation in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
    Anatol J Cardiol. 2023;27:479-485.
    PubMed    
    Abstract available
    
    

32. AYON RJ, Yuan JX
    Revisiting the Role of KCNA5 in Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2023;69:123-125.
    PubMed    
    
    
    

33. FRUMP AL, Machado RF
    Bound Together: RNA Binding Protein Quaking, STAT3, and Pulmonary Vascular Remodeling.
    Am J Respir Cell Mol Biol. 2023;69:119-120.
    PubMed    
    
    
    

34. YIN Q, Wang S, Yang J, Fan C, et al
    Nobiletin attenuates monocrotaline-induced pulmonary arterial hypertension through PI3K/Akt/STAT3 pathway.
    J Pharm Pharmacol. 2023;75:1100-1110.
    PubMed    
    Abstract available
    
    

35. JHA N, Divya MB, Jha AK
    Management and outcomes of pulmonary artery hypertension and Eisenmenger syndrome during pregnancy: a prospective observational cohort study.
    BJOG. 2023;130:1258-1268.
    PubMed    
    Abstract available
    
    

36. VERA-ZAMBRANO A, Lago-Docampo M, Gallego N, Franco-Gonzalez JF, et al
    Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2023;69:147-158.
    PubMed    
    Abstract available
    
    

37. MEMIC SANCAR K, Yildiz M, Kahraman S, Uygur B, et al
    Early echocardiographic evaluation of right ventricular load adaptability after sequential combination treatment in pulmonary arterial hypertension.
    Herz. 2023;48:316-324.
    PubMed    
    Abstract available
    
    

38. NAKAGAWA A, Nakamura N, Torii S, Goto S, et al
    Acute pulmonary hypertension due to microthrombus formation following COVID-19 vaccination: a case report.
    Eur Heart J Case Rep. 2023;7:ytad353.
    PubMed    
    Abstract available
    
    

39. XUE C, Gu X, Han J, Zhao Y, et al
    Echocardiographic features and influencing factors of pulmonary hypertension of total anomalous pulmonary venous connection in adults.
    J Thorac Dis. 2023;15:3791-3799.
    PubMed    
    Abstract available
    
    

40. LIU Y, Li H, Li Y, Zhang J, et al
    Outcomes of pregnancy in women with different types of pulmonary hypertension.
    BMC Cardiovasc Disord. 2023;23:391.
    PubMed    
    Abstract available
    
    

41. YOO HHB
    Transthoracic Echocardiography in Pulmonary Hypertension: Easy Tool, but Caution is Needed!
    Arq Bras Cardiol. 2023;120:e20230380.
    PubMed    
    
    
    

42. REZENDE CF, Mancuzo EV, Nunes MDCP, Correa RA, et al
    Accuracy of Transthoracic Echocardiogram as a Screening Method in the Clinical Practice of Pulmonary Hypertension Investigation.
    Arq Bras Cardiol. 2023;120:e20220461.
    PubMed    
    Abstract available
    
    

43. DONAHOE LL, Snelgrove JW, de Perrot M, Sermer M, et al
    Pregnancy and pulmonary hypertension in the pre-lung transplant patient: Successfully saving two lives with extracorporeal lung support.
    JTCVS Tech. 2023;20:186-191.
    PubMed    
    
    
    

44. ZHENG X, Cao J, Zhang G
    Stunning tornado: severe pulmonary hypertension due to cor triatriatum sinister.
    Eur Heart J. 2023 Aug 9:ehad505. doi: 10.1093.
    PubMed    
    
    
    

45. LAKSHMINRUSIMHA S, Madappa R
    Acute Pulmonary Hypertension of Early Infancy - Is Thiamine Deficiency the Only Cause?
    Indian Pediatr. 2023 Jun 21:S097475591600557.
    PubMed    
    
    
    

46. MILLER M, Johnston N, Livengood I, Spinelli M, et al
    A topological data analysis study on murine pulmonary arterial trees with pulmonary hypertension.
    Math Biosci. 2023 Aug 5:109056. doi: 10.1016/j.mbs.2023.109056.
    PubMed    
    Abstract available
    
    

47. YOGESWARAN A, Zedler D, Richter MJ, Steinke S, et al
    Hepatorenal dysfunction in patients with chronic thromboembolic pulmonary hypertension.
    Front Med (Lausanne). 2023;10:1207474.
    PubMed    
    Abstract available
    
    

48. LIAO Z, Liu K, Ding S, Zhao Q, et al
    Automatic echocardiographic evaluation of the probability of pulmonary hypertension using machine learning.
    Pulm Circ. 2023;13:e12272.
    PubMed    
    Abstract available
    
    

49. YOSHIDA S, Kreger AM, Gittes GK
    Intra-amniotic sildenafil treatment improves lung blood flow and pulmonary hypertension in congenital diaphragmatic hernia rats.
    Front Bioeng Biotechnol. 2023;11:1195623.
    PubMed    
    Abstract available
    
    

50. D'ALTO M, Liccardo B, Di Maio M, Del Giudice C, et al
    Lung Ultrasound, Echocardiography and Fluid Challenge for the Differential Diagnosis of Pulmonary Hypertension.
    J Am Soc Echocardiogr. 2023 Aug 4:S0894-7317(23)00411.
    PubMed    
    Abstract available
    
    

51. BACZYNSKI M, Jasani B, De Castro C, Dani C, et al
    Association between immediate oxygenation response and survival in preterm infants receiving rescue inhaled nitric oxide therapy for hypoxemia from pulmonary hypertension: A systematic review and meta-analysis.
    Early Hum Dev. 2023;184:105841.
    PubMed    
    Abstract available
    
    

52. KUNDU P, Schafer M, Le L, Thomas T, et al
    Three-Dimensional, Right Ventricular Surface Strain Computation From Three Dimensional Echocardiographic Images From Patients With Pediatric Pulmonary Hypertension.
    J Biomech Eng. 2023 Aug 5:1-39. doi: 10.1115/1.4063121.
    PubMed    
    Abstract available
    
    

53. ROSS CE
    Pulmonary hypertension in pediatric cardiac arrest: A pressure point for a personalized approach.
    Resuscitation. 2023 Aug 2:109918. doi: 10.1016/j.resuscitation.2023.109918.
    PubMed    
    
    
    

54. HUANG T, Zeng Y, Yang Y, Fan H, et al
    Comprehensive analysis of m(6)A methylomes in idiopathic pulmonary arterial hypertension.
    Epigenetics. 2023;18:2242225.
    PubMed    
    Abstract available
    
    

55. LIU M, He H, Fan F, Qiu L, et al
    Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR/HSP90alpha axis.
    J Mol Cell Cardiol. 2023;181:15-30.
    PubMed    
    Abstract available
    
    

56. JIANG J, Liu S, Yang H, Lv Y, et al
    Application of transcriptomics and proteomics in pulmonary arterial hypertension.
    Per Med. 2023;20:183-192.
    PubMed    
    Abstract available
    
    

57. ERMERAK NO, Yildizeli SO, Kocakaya D, Mutlu B, et al
    Surgical Treatment of Another Sequalae of COVID-19: Post-COVID CTEPH.
    Thorac Cardiovasc Surg. 2023;71:413-417.
    PubMed    
    Abstract available
    
    

58. YUCHI Y, Suzuki R, Saito T, Yasumura Y, et al
    Echocardiographic characteristics of dogs with pulmonary hypertension secondary to respiratory diseases.
    J Vet Intern Med. 2023 Aug 18. doi: 10.1111/jvim.16836.
    PubMed    
    Abstract available
    
    

59. COSTA-RODRIGUEZ N, Garcia-Rodriguez SN, Matos JI, Falcon-Cordon Y, et al
    Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?
    Parasit Vectors. 2023;16:292.
    PubMed    
    Abstract available
    
    

60. KUANG M, Chen Y, Xing Y, Du M, et al
    Echocardiographic evaluation of right heart failure which might be associated with DNA damage response in SU5416-hypoxia induced pulmonary hypertension rat model.
    Respir Res. 2023;24:202.
    PubMed    
    Abstract available
    
    

61. OLSSON KM, Corte TJ, Kamp JC, Montani D, et al
    Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management.
    Lancet Respir Med. 2023 Aug 14:S2213-2600(23)00259.
    PubMed    
    Abstract available
    
    

62. DELCROIX M, de Perrot M, Jais X, Jenkins DP, et al
    Chronic thromboembolic pulmonary hypertension: realising the potential of multimodal management.
    Lancet Respir Med. 2023 Aug 14:S2213-2600(23)00292.
    PubMed    
    Abstract available
    
    

63. NEWMAN J, Pepke-Zaba J
    Illuminating the many faces of pulmonary hypertension.
    Lancet Respir Med. 2023 Aug 14:S2213-2600(23)00291.
    PubMed    
    
    
    

64. LI Y, Fu Y, Liu Y, Zhao D, et al
    An optimized machine learning method for predicting wogonin therapy for the treatment of pulmonary hypertension.
    Comput Biol Med. 2023;164:107293.
    PubMed    
    Abstract available
    
    

65. MAIMAITIAILI N, Zeng Y, Ju P, Zhakeer G, et al
    NLRC3 deficiency promotes hypoxia-induced pulmonary hypertension development via IKK/NF-kappaB p65/HIF-1alpha pathway.
    Exp Cell Res. 2023 Aug 14:113755. doi: 10.1016/j.yexcr.2023.113755.
    PubMed    
    Abstract available
    
    

66. YUAN C, Zhang Q
    Risk factors for microalbuminuria in adult Tibetan patients with high-altitude pulmonary hypertension: a cross-sectional study.
    Cardiovasc Diagn Ther. 2023;13:336-344.
    PubMed    
    Abstract available
    
    

67. JACOBS S, Payne C, Shaboodien S, Kgatla T, et al
    Gut microbiota crosstalk mechanisms are key in pulmonary hypertension: The involvement of melatonin is instrumental too.
    Pulm Circ. 2023;13:e12277.
    PubMed    
    Abstract available
    
    

68. ZHANG S, Tian YN, Song ZY, Wang XT, et al
    [Panax notoginseng saponins improve monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting ADAM10/Notch3 signaling pathway].
    Sheng Li Xue Bao. 2023;75:503-511.
    PubMed    
    Abstract available
    
    

69. LIU XX, Chen AD, Pan Y, Zhang F, et al
    [Angiotensin-(1-7) improves endothelium-dependent vasodilation in rats with monocrotaline-induced pulmonary arterial hypertension].
    Sheng Li Xue Bao. 2023;75:497-502.
    PubMed    
    Abstract available
    
    

70. LIAN G, You J, Lin W, Gao G, et al
    Bioinformatics analysis of the immune cell infiltration characteristics and correlation with crucial diagnostic markers in pulmonary arterial hypertension.
    BMC Pulm Med. 2023;23:300.
    PubMed    
    Abstract available
    
    

71. RAWLINGS GH, Novakova B, Armstrong I, Thompson AR, et al
    A systematic review of psychological interventions in adults with pulmonary hypertension: Is the evidence-base disproportionate to the problem?
    Clin Respir J. 2023 Aug 15. doi: 10.1111/crj.13685.
    PubMed    
    Abstract available
    
    

72. JIN Y, Guo G, Wang C, Jiang B, et al
    Association of red cell distribution width with pulmonary arterial hypertension in patients with mixed connective tissue disease.
    BMC Pulm Med. 2023;23:299.
    PubMed    
    Abstract available
    
    

73. KACHABI A, Colebank MJ, Chesler N
    Subject-specific one-dimensional fluid dynamics model of chronic thromboembolic pulmonary hypertension.
    Res Sq. 2023 Aug 3:rs.3.rs-3214385. doi: 10.21203/rs.3.rs-3214385.
    PubMed    
    Abstract available
    
    

74. FERNANDEZ-GONZALEZ A, Mukhia A, Nadkarni J, Willis GR, et al
    Immunoregulatory macrophages modify local pulmonary immunity and ameliorate hypoxic-pulmonary hypertension.
    bioRxiv. 2023 Aug 2:2023.07.31.551394. doi: 10.1101/2023.07.31.551394.
    PubMed    
    Abstract available
    
    

75. PUTRA SD, Prakoso R, Sembiring AA, Sakti DDA, et al
    Palliative interatrial septum stenting with a vascular stent in a chronic thromboembolic pulmonary hypertension patient: Is it beneficial?
    Egypt Heart J. 2023;75:70.
    PubMed    
    Abstract available
    
    

76. DURMUS N, Chen WC, Park SH, Marsh LM, et al
    Resistin-like Molecule alpha and Pulmonary Vascular Remodeling: A Multi-Strain Murine Model of Antigen and Urban Ambient Particulate Matter Co-Exposure.
    Int J Mol Sci. 2023;24:11918.
    PubMed    
    Abstract available
    
    

77. KATZ MG, Hadas Y, Vincek A, Freage-Kahn L, et al
    Acid ceramidase gene therapy ameliorates pulmonary arterial hypertension with right heart dysfunction.
    Respir Res. 2023;24:197.
    PubMed    
    Abstract available
    
    

78. DELCROIX M, Belge C, Maleux G, Godinas L, et al
    Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension.
    Semin Respir Crit Care Med. 2023 Aug 11. doi: 10.1055/s-0043-1770122.
    PubMed    
    Abstract available
    
    

79. YUAN J, Li S, Han Y, Li F, et al
    Restoration of miR-328a-5p function curtails hypoxic pulmonary hypertension through a mechanism involving PIN1/GSK3beta/beta-catenin axis.
    Int Immunopharmacol. 2023;123:110599.
    PubMed    
    Abstract available
    
    

80. AMPATZIDOU F, Drosos O, Madesis A, Drossos G, et al
    Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH).
    Kardiochir Torakochirurgia Pol. 2023;20:129-131.
    PubMed    
    
    
    

81. ROMERO-ZERTUCHE D, Santos-Martinez LE, Loaiza-Sanchez JF, Moreno-Ruiz LA, et al
    Echocardiographic analysis of pulmonary arterial systolic pressure in pulmonary hypertension.
    Arch Cardiol Mex. 2023;93:267-275.
    PubMed    
    Abstract available
    
    

82. SAHAY S, Lane J, Sharpe MG, Toth D, et al
    Impact on Pulmonary Hypertension Hemodynamic Classification Based on the Methodology Used to Measure Pulmonary Artery Wedge Pressure and Cardiac Output.
    Ann Am Thorac Soc. 2023 Aug 10. doi: 10.1513/AnnalsATS.202303.
    PubMed    
    Abstract available
    
    

83. JOSE A, Elwing JM, Kawut SM, Pauciulo MW, et al
    Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertension.
    Commun Biol. 2023;6:826.
    PubMed    
    Abstract available
    
    

84. PAHAL P, Sharma S, Braga CL, Santos RT, et al
    Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension.
    Life Sci. 2023;329:121988.
    PubMed    
    Abstract available
    
    

85. NANDULA PS, Shah SD, Caputo A, Papa S, et al
    Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
    Curr Heart Fail Rep. 2023;20:263-270.
    PubMed    
    Abstract available
    
    

86. ZI-YANG Y, Nanshan X, Dongling L, Tao H, et al
    ACE2 gene polymorphisms are associated with elevated pulmonary artery pressure in congenital heart diseases.
    Gene. 2023;882:147642.
    PubMed    
    Abstract available
    
    

87. ABU-HANNA J, Anastasakis E, Patel JA, Eddama MMR, et al
    Prostacyclin mimetics inhibit DRP1-mediated pro-proliferative mitochondrial fragmentation in pulmonary arterial hypertension.
    Vascul Pharmacol. 2023;151:107194.
    PubMed    
    Abstract available
    
    

88. PALMIERO G, Monda E, Verrillo F, Dongiglio F, et al
    Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis.
    Int J Cardiol. 2023;388:131147.
    PubMed    
    Abstract available
    
    

89. MARCUS B, Marynen F, Fieuws S, Van Beersel D, et al
    The perioperative use of inhaled prostacyclins in cardiac surgery: a systematic review and meta-analysis.
    Can J Anaesth. 2023 Jun 28. doi: 10.1007/s12630-023-02520.
    PubMed    
    Abstract available
    
    

90. YU X, Wu M, Meng Q, Zhu W, et al
    Ligustrazine alleviates pulmonary arterial hypertension in rats by promoting the formation of myocardin transcription complex in the nucleus of pulmonary artery smooth muscle cells.
    Clin Transl Sci. 2023;16:1369-1380.
    PubMed    
    Abstract available
    
    

91. CULLEY MK, Rao RJ, Mehta M, Zhao J, et al
    Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function.
    Vascul Pharmacol. 2023;151:107181.
    PubMed    
    Abstract available
    
    

92. SANZ J, Nelson KF
    Towards Noninvasive Evaluation of the Right Heart-Pulmonary Circulation Unit.
    JACC Cardiovasc Imaging. 2023;16:1035-1037.
    PubMed    
    
    
    

93. ZHONG L, Leng S, Alabed S, Chai P, et al
    Pulmonary Artery Strain Predicts Prognosis in Pulmonary Arterial Hypertension.
    JACC Cardiovasc Imaging. 2023;16:1022-1034.
    PubMed    
    Abstract available
    
    

94. YAN J, Duan Y, Cheng M
    Clinical Diagnostic Value of Serum GABA, NE, ET-1, and VEGF in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension.
    Int J Chron Obstruct Pulmon Dis. 2023;18:1803-1813.
    PubMed    
    Abstract available
    
    

95. KARIA N, Howard L, Johnson M, Kiely DG, et al
    Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study.
    Eur Heart J. 2023 Aug 24:ehad532. doi: 10.1093.
    PubMed    
    Abstract available
    
    

96. NAKAMURA J, Tsujino I, Shima H, Nakaya T, et al
    Impact of cancer on the prevalence, management, and outcome of patients with chronic thromboembolic pulmonary hypertension.
    J Thromb Thrombolysis. 2023 Aug 24. doi: 10.1007/s11239-023-02868.
    PubMed    
    Abstract available
    
    

97. MAHENDRA M, Chu P, Amin EK, Nawaytou H, et al
    Associated radiation exposure from medical imaging and excess lifetime risk of developing cancer in pediatric patients with pulmonary hypertension.
    Pulm Circ. 2023;13:e12282.
    PubMed    
    Abstract available
    
    

98. DAI M, Zhang C, Li C, Wang Q, et al
    Clinical characteristics and prognosis in systemic lupus erythematosus-associated pulmonary arterial hypertension based on consensus clustering and risk prediction model.
    Arthritis Res Ther. 2023;25:155.
    PubMed    
    Abstract available
    
    

99. LI M, Tang M, Zhao C, Dang P, et al
    Prognostic Potential of Pulmonary Hypertension in Patients with Hematologic Malignancy.
    Adv Ther. 2023 Aug 23. doi: 10.1007/s12325-023-02639.
    PubMed    
    Abstract available
    
    

100. GUTENSCHWAGER DW, Patel A, Soyad AT, Patel S, et al
     Provision of ambrisentan from a health-system specialty pharmacy affiliated with a pulmonary hypertension Center of Comprehensive Care.
     Am J Health Syst Pharm. 2023 Aug 23:zxad191. doi: 10.1093.
     PubMed    
     Abstract available
     
     

101. TEIXEIRA-FONSECA JL, Joviano-Santos JV, da Silva Alcantara F, de Lima Conceicao MR, et al
     Evaluation of right atrium structure and function in a rat model of monocrotaline-induced pulmonary hypertension: Exploring the possible antiarrhythmic properties of amiodarone.
     Clin Exp Pharmacol Physiol. 2023 Aug 23. doi: 10.1111/1440-1681.13813.
     PubMed    
     Abstract available
     
     

102. NAUD R, Bermudez J, Resseguier N, Nieves A, et al
     Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases.
     ERJ Open Res. 2023;9:00027-2023.
     PubMed    
     Abstract available
     
     

103. JANSA P, Kopec G, Torbicki A, Sadushi-Kolici R, et al
     The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil.
     Pulm Circ. 2023;13:e12274.
     PubMed    
     Abstract available
     
     

104. FENG X, Wang K, Yang T, Dang B, et al
     Overexpressed microRNA (miR)-382-3p promoted vascular remodeling via suppressing autophagy-related protein 7 (ATG7) in chronic thromboembolic pulmonary hypertension.
     Curr Mol Med. 2023 Aug 22. doi: 10.2174/1566524023666230822120453.
     PubMed    
     Abstract available
     
     

105. HANER WASSERSTEIN D, Frishman WH
     Impact of Balloon Pulmonary Angioplasty on Right Ventricular Function in Patients With Chronic Thromboembolic Pulmonary Hypertension.
     Cardiol Rev. 2023 Aug 22. doi: 10.1097/CRD.0000000000000571.
     PubMed    
     Abstract available
     
     

106. HRDLICKA J, Jurka M, Bircakova B, Ambroz D, et al
     Even non-expert radiologists report chronic thromboembolic pulmonary hypertension (CTEPH) on CT pulmonary angiography with high sensitivity and almost perfect agreement.
     Eur Radiol. 2023 Aug 22. doi: 10.1007/s00330-023-10098.
     PubMed    
     Abstract available
     
     

107. PUST F, Deis T, Larsson J, Hansen BL, et al
     Importance of heart failure duration for development of pulmonary hypertension in advanced heart failure.
     Int J Cardiol. 2023 Aug 19:131232. doi: 10.1016/j.ijcard.2023.131232.
     PubMed    
     Abstract available
     
     

108. CHEN R, Wang H, Zheng C, Zhang X, et al
     Polo-like kinase 1 promotes pulmonary hypertension.
     Respir Res. 2023;24:204.
     PubMed    
     Abstract available
     
     

109. FANG A, Mayorga-Carlin M, Han P, Cassady S, et al
     Risk factors and treatment interventions associated with incomplete thrombus resolution and pulmonary hypertension after a pulmonary embolism.
     J Vasc Surg Venous Lymphat Disord. 2023 Aug 16:S2213-333X(23)00317.
     PubMed    
     Abstract available
     
     

110. SEITLER S, Dimopoulos K, Ernst S, Price LC, et al
     Medical Emergencies in Pulmonary Hypertension.
     Semin Respir Crit Care Med. 2023 Aug 18. doi: 10.1055/s-0043-1770120.
     PubMed    
     Abstract available
     
     

111. LECHARTIER B, Kularatne M, Jais X, Humbert M, et al
     Updated Hemodynamic Definition and Classification of Pulmonary Hypertension.
     Semin Respir Crit Care Med. 2023 Aug 18. doi: 10.1055/s-0043-1770115.
     PubMed    
     Abstract available
     
     

112. BREINIG S, Ehlinger V, Roze JC, Storme L, et al
     Pulmonary hypertension among preterm infants born at 22 through 32 weeks gestation in France: Prevalence, survival, morbidity and management in the EPIPAGE-2 cohort study.
     Early Hum Dev. 2023;184:105837.
     PubMed    
     Abstract available
     
     

113. PAHAL P, Sharma S, Panchal J, Jaiswal S, et al
     Development of novel bosentan analogues as endothelin receptor antagonists for pulmonary arterial hypertension.
     Eur J Med Chem. 2023;259:115681.
     PubMed    
     Abstract available
     
     

114. TELLO K, Naeije R, de Man F, Guazzi M, et al
     Pathophysiology of the right ventricle in health and disease: an update.
     Cardiovasc Res. 2023;119:1891-1904.
     PubMed    
     Abstract available
     
     

115. MENG CY, Zou JZ, Wang Y, Wei YD, et al
     Pathological findings in congenital diaphragmatic hernia on necropsy studies: A single-center case series.
     Pediatr Pulmonol. 2023 Jun 28. doi: 10.1002/ppul.26565.
     PubMed    
     Abstract available
     
     

116. KANE CJ, Lara-Breitinger KM, Alabdaljabar MS, Nkomo VT, et al
     Pulmonary artery pulsatility index in patients with tricuspid valve regurgitation: a simple non-invasive tool for risk stratification.
     Eur Heart J Cardiovasc Imaging. 2023;24:1210-1221.
     PubMed    
     Abstract available
     
     

117. GOTSMAN I, Abu Ghosh Z, Zwas DR, Amir O, et al
     Pulmonary Hypertension Severity in Heart Failure: Clinical Characteristics and Impact on Outcome.
     Am J Cardiol. 2023;204:29-31.
     PubMed    
     
     
     

118. OZCAN KAHRAMAN B, Tanriverdi A, Savci S, Odaman H, et al
     Effects of Inspiratory Muscle Training in Patients With Pulmonary Hypertension.
     Am J Cardiol. 2023;203:406-413.
     PubMed    
     Abstract available
     
     

119. VEDAGE NA, Forfia PR, Grafstrom A, Vaidya A, et al
     Virtual Echocardiography Screening Tool Identifies Pulmonary Arterial Hypertension Significantly Earlier Than High-Risk Clinical Diagnosis.
     Am J Cardiol. 2023;201:328-334.
     PubMed    
     Abstract available
     
     

120. SHAH AH, Oechslin E, Benson L, Crean AM, et al
     Long-Term Outcomes of Unrepaired Isolated Partial Anomalous Pulmonary Venous Connection With an Intact Atrial Septum.
     Am J Cardiol. 2023;201:232-238.
     PubMed    
     Abstract available
     
     

121. GOMEZ-RODRIGUEZ C, Tadeo-Espinoza H, Solis-Huerta F, Leal-Villarreal MAJ, et al
     Hemodynamic Evaluation of Right-Sided Congestion With Doppler Ultrasonography in Pulmonary Hypertension.
     Am J Cardiol. 2023;203:459-462.
     PubMed    
     
     
     

122. MASSON B, Saint-Martin Willer A, Dutheil M, Penalva L, et al
     Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension.
     Am J Physiol Lung Cell Mol Physiol. 2023;325:L246-L261.
     PubMed    
     Abstract available
     
     

123. PANKOKE S, Schweitzer T, Bikker R, Pich A, et al
     Obesity impacts hypoxia adaptation of the lung.
     Am J Physiol Lung Cell Mol Physiol. 2023;325:L352-L359.
     PubMed    
     Abstract available
     
     

124. FORBES LM, Bull TM, Lahm T, Lawley JS, et al
     Right Ventricular Response to Acute Hypoxia among Healthy Humans.
     Am J Respir Crit Care Med. 2023;208:333-336.
     PubMed    
     
     
     

125. ROCHESTER CL, Alison JA, Carlin B, Jenkins AR, et al
     Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline.
     Am J Respir Crit Care Med. 2023;208:e7-e26.
     PubMed    
     Abstract available
     
     

126. BRITTAIN EL, Tedford RJ, Maron BA
     Reply to: Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
     Am J Respir Crit Care Med. 2023 Aug 10. doi: 10.1164/rccm.202307-1180.
     PubMed    
     
     
     

127. WU Y, Su X, Wang J, Zhang H, et al
     Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
     Am J Respir Crit Care Med. 2023 Aug 10. doi: 10.1164/rccm.202306-1076.
     PubMed    
     
     
     

128. HAN MK
     From Conundrum to Cures, Pioneering Breakthroughs in Chronic Obstructive Pulmonary Disease Research: Introduction to an AJRCCM Special Issue.
     Am J Respir Crit Care Med. 2023;208:339-340.
     PubMed    
     
     
     

129. MOINZADEH P, Bonella F, Oberste M, Weliwitage J, et al
     Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival - a large cohort study of the German network for systemic sclerosis.
     Chest. 2023 Aug 13:S0012-3692(23)05274-1. doi: 10.1016/j.chest.2023.
     PubMed    
     Abstract available
     
     

130. KULARATNE M, Eyries M, Savale L, Humbert M, et al
     Isolated Pulmonary Arteriovenous Malformations Associated With BMPR2 Pathogenic Variants.
     Chest. 2023;164:e23-e26.
     PubMed    
     Abstract available
     
     

131. ZHOU X, Jiang Y, Wang Y, Fan L, et al
     Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension.
     Circ Res. 2023 Aug 17. doi: 10.1161/CIRCRESAHA.122.321200.
     PubMed    
     Abstract available
     
     

132. KHAN SL, Mathai SC
     Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?
     Curr Opin Pulm Med. 2023;29:380-390.
     PubMed    
     Abstract available
     
     

133. KABADI A, Kerr K, Fernandes TM
     Updates in the diagnosis and management of chronic thromboembolic disease.
     Curr Opin Pulm Med. 2023;29:340-347.
     PubMed    
     Abstract available
     
     

134. DESHWAL H, Sulica R
     Approach to the hospitalized patient with pulmonary arterial hypertension.
     Curr Opin Pulm Med. 2023;29:329-339.
     PubMed    
     Abstract available
     
     

135. PAN HM, McClelland RL, Moutchia J, Appleby DH, et al
     Heterogeneity of treatment effects by risk in pulmonary arterial hypertension.
     Eur Respir J. 2023;62:2300190.
     PubMed    
     Abstract available
     
     

136. OLSSON KM, Fuge J, Park DH, Kamp JC, et al
     Effects of sotatercept on lung diffusion capacity and blood gases in patients with pulmonary arterial hypertension.
     Eur Respir J. 2023;62:2301070.
     PubMed    
     
     
     

137. ALABED S, Garg P, Alandejani F, Dwivedi K, et al
     Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension.
     Eur Respir J. 2023;62:2202225.
     PubMed    
     Abstract available
     
     

138. COSTANZO MR, Marwick TH
     Right Atrium as Barometer of Right Ventricular Stiffness and Treatment Responsiveness in Precapillary Pulmonary Hypertension.
     J Am Coll Cardiol. 2023;82:718-720.
     PubMed    
     
     
     

139. WESSELS JN, van Wezenbeek J, de Rover J, Smal R, et al
     Right Atrial Adaptation to Precapillary Pulmonary Hypertension: Pressure-Volume, Cardiomyocyte, and Histological Analysis.
     J Am Coll Cardiol. 2023;82:704-717.
     PubMed    
     Abstract available
     
     

140. FERNANDES TM, Kim NH, Kerr KM, Auger WR, et al
     Distal vessel pulmonary thromboendarterectomy: Results from a single institution.
     J Heart Lung Transplant. 2023;42:1112-1119.
     PubMed    
     Abstract available
     
     

141. STOLFO D, Barbisan D, Ameri P, Lombardi CM, et al
     Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension.
     J Heart Lung Transplant. 2023;42:1082-1092.
     PubMed    
     Abstract available
     
     

142. ZHANG J, Kan J, Wei Y, Zhang C, et al
     Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial.
     J Heart Lung Transplant. 2023;42:1140-1151.
     PubMed    
     Abstract available
     
     

143. PIENN M, Gertz RJ, Gerhardt F, Kroger JR, et al
     CT-derived Lung Vessel Morphology Correlates with Prognostic Markers in Pre-capillary Pulmonary Hypertension.
     J Heart Lung Transplant. 2023 Aug 22:S1053-2498(23)01973.
     PubMed    
     Abstract available
     
     

144. ZHU F, Ibarra Rios D, Joye S, Baczynski M, et al
     Cardiopulmonary physiological effects of diuretic therapy in preterm infants with chronic pulmonary hypertension.
     J Perinatol. 2023 Aug 7. doi: 10.1038/s41372-023-01742.
     PubMed    
     Abstract available
     
     

145. STEFLIK HJ, Wessler LA, Shugart WW, Wagner CL, et al
     Indomethacin patent ductus arteriosus prophylaxis in the modern era: renal implications.
     J Perinatol. 2023;43:1045-1046.
     PubMed    
     
     
     

146. AWAD MA, Cires-Drouet R, Ramani G, Leibowitz JL, et al
     Pulmonary Thromboendarterectomy in Hospitalized versus Elective Patients with Chronic Thromboembolic Pulmonary Hypertension.
     J Thorac Cardiovasc Surg. 2023 Aug 21:S0022-5223(23)00728.
     PubMed    
     Abstract available
     
     

147. TSEGA W, Awoke W, Sendekie AK, Dagnew EM, et al
     Electrocardiogram and echocardiography findings and the outcomes of patients with myocardial infarction: Retrospective study in tertiary care hospitals in Northwest Ethiopia.
     PLoS One. 2023;18:e0288698.
     PubMed    
     Abstract available